evaluating-critical-asset-safeguards-for-pharmaceutical (1)

Evaluating Critical Asset Safeguards for Pharmaceutical Manufacturers

Pharmaceutical and Biotechnology companies create products that generate billions of dollars in annual sales. As product demand and manufacturing outputs increase for these products, so do the demands for trouble free manufacturing equipment, performance and reliability requirements. One central issue for these companies’ supply chains is the lack of an effective risk management process for […]